KOSP Insider Trading Activity and SEC Form 4 Filings
KOSP insider trading summary
No open-market insider purchases or sales of Kos Pharmaceuticals Inc (KOSP) have been reported on SEC Form 4 in the past 12 months.
Latest KOSP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 6, 2006 | Ralf Rosskamp | EVP, Research and Development | Sell | $962K (12,500 @ $76.95) |
| Mar 16, 2006 | Juan F Rodriguez | SVP, Controller & Corp. Admin. | Sell | $163K (3,200 @ $50.80) |
| Mar 16, 2006 | Juan F Rodriguez | SVP, Controller & Corp. Admin. | Sell | $193K (3,800 @ $50.80) |
| Mar 14, 2006 | Robert E Baldini | Director | Sell | $366K (7,500 @ $48.80) |
| Mar 13, 2006 | Robert E Baldini | Director | Sell | $124K (2,500 @ $49.40) |
| Mar 13, 2006 | Mark E McGovern | EVP, Chief Medical Officer | Sell | $613K (12,500 @ $49.00) |
| Mar 13, 2006 | Mark E McGovern | EVP, Chief Medical Officer | Sell | $796K (16,250 @ $49.00) |
| Mar 10, 2006 | Richard King | EVP, Commercial Operations | Sell | $250K (5,000 @ $50.00) |
| Mar 9, 2006 | Robert E Baldini | Director | Sell | $119K (2,500 @ $47.50) |
| Mar 7, 2006 | Robert E Baldini | Director | Sell | $117K (2,500 @ $46.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.